|Articles|November 1, 2016
- Pharmaceutical Executive-11-01-2016
- Volume 36
- Issue 11
Pharmaceutical Executive, November 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Pharm Exec's 2017 Pipeline Reportabout 9 years ago
Digital Disruption is Coming: Are You Ready?about 9 years ago
8 Winning Commercial Portfolio Strategiesabout 9 years ago
Building Market Access Competencies for the Futureabout 9 years ago
Loss of Exclusivity: Strategies to Maximize Product Valueabout 9 years ago
Flipping the Generics Map: Apotex's Jeremy Desaiabout 9 years ago
The Pipeline: Pressures from Beyondabout 9 years ago
Has Gastein Peaked?about 9 years ago
Country Report: SwitzerlandNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Nimbus Therapeutics and Eli Lilly Enter $1.3 Billion License Agreement and Research Collaboration for Oral Obesity Treatments
2
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
3
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
4
Parental Control: Why Pharma’s Strongest Asset May Be Its Parent Brand
5